PetVivo Holdings, Inc. (OTC:PETV)
| Market Cap | $11.76M-75.2% |
| Revenue (ttm) | $1.09M-22.5% |
| Net Income | -$8.72M+8.2% |
| EPS | -$0.25+38.4% |
| Shares Out | 37.95M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,497 |
| Open | $0.27 |
| Previous Close | $0.26 |
| Day's Range | $0.27 - $0.31 |
| 52-Week Range | $0.24 - $1.44 |
| Beta | 1.44 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Feb 16, 2027 |
About PETV
PetVivo Holdings, Inc. operates as a biomedical technology firm, specializing in the invention, commercialization, and licensing of advanced medical devices and biomaterials intended to treat a variety of ailments and diseases affecting animals. Its flagship product is Spryng, an intra-articular injection administered by veterinarians to effectively alleviate lameness and joint conditions, such as osteoarthritis, in canines and equines. The company's development pipeline further includes seventeen therapeutic devices poised for both veterinary and human clinical applications. Founded in 2009, PetVivo Holdings, Inc. maintains its corporate headquarters in Minneapolis, Minnesota.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Next catalysts
- Feb 16, 2027Earnings report
$PETV stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in PETV holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by PETV's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
PETV Estimated quarterly lobbying spending
Source: U.S. Senate LDA
PETV Revenue by Segment
| Unrealized Loss on Change in Derivative Liabilities | $320.40K | 47.86% |
| Loss on termination of license agreement | $237.53K | 35.48% |
| Other Income | $111.52K | 16.66% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New PETV patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to PETV from public contracts
Source: USAspending.gov
Bull Case vs Bear Case
AI-generated from PETV’s recent data — informational, not investment advice
What’s Behind the Score
Recent Insider Activity
Insider Score Trend Over Time
+0.0 since Sep 25Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.
